Tirofiban hydrochloride monohydrate CAS#: 150915-40-5; ChemWhat Code: 41528
Identification
Product Name | Tirofiban hydrochloride monohydrate |
IUPAC Name | (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid;hydrate;hydrochloride |
Molecular Structure | |
CAS Registry Number | 150915-40-5 |
EINECS Number | No data available |
MDL Number | MFCD07368623 |
Beilstein Registry Number | No data available |
Synonyms | tirofiban hydrochloride monohydratetirofiban hydrochloride |
Molecular Formula | C22H36N2O5S.HCl.H2O |
Molecular Weight | 495.07 |
InChI | InChI=1S/C22H36N2O5S.ClH.H2O/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18;;/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26);1H;1H2/t21-;;/m0../s1 |
InChI Key | HWAAPJPFZPHHBC-FGJQBABTSA-N |
Canonical SMILES | CCCCS(=O)(=O)N[C@@H](Cc1ccc(cc1)OCCCCC2CCNCC2)C(=O)O.O.Cl |
Patent Information | ||
Patent ID | Title | Publication Date |
US2002/115655 | Calcium channel blockers | 2002 |
US2003/207918 | Method for inhibiting platelet aggregation | 2003 |
Physical Data
Appearance | White or almost white powder |
Solubility | DMSO: >12 mg/mL when heated to 60°C |
Flash Point | 88 ºC |
Refractive index | No data available |
Sensitivity | No data available |
Spectra
No data available |
Route of Synthesis (ROS)
Conditions | Yield |
Stage #1: N-n-butylsulfonyl-O-(4-(pyridin-4-yl)but-3-yn-1-yl)-L-tyrosine With 5%-palladium/activated carbon; hydrogen; acetic acid at 60℃; for 5h; Autoclave; Stage #2: With hydrogenchloride In Isopropyl acetate; water at 20℃; for 5h; | 25.9g |
Safety and Hazards
Pictogram(s) | |
Signal | Danger |
GHS Hazard Statements | H302 (44.9%): Harmful if swallowed [Warning Acute toxicity, oral] H315 (55.1%): Causes skin irritation [Warning Skin corrosion/irritation] H318 (44.9%): Causes serious eye damage [Danger Serious eye damage/eye irritation] H319 (55.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (53.8%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] H372 (44.9%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Information may vary between notifications depending on impurities, additives, and other factors. |
Precautionary Statement Codes | P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (The corresponding statement to each P-code can be found at the GHS Classification page.) |
Other Data
Transportation | NONH for all modes of transport |
Under the room temperature and away from light | |
HS Code | No data available |
Storage | Under the room temperature and away from light |
Shelf Life | 1 year |
Market Price | USD |
Druglikeness | |
Lipinski rules component | |
Molecular Weight | 495.08 |
HBA | 7 |
HBD | 4 |
Matching Lipinski Rules | 3 |
Veber rules component | |
Polar Surface Area (PSA) | 113.11 |
Rotatable Bond (RotB) | 14 |
Matching Veber Rules | 1 |
Use Pattern |
Tirofiban hydrochloride is an effective non-peptide, glycoprotein IIb / IIIa inhibitor. Prevent platelet aggregation and thrombosis. |
Buy Reagent | |
No reagent supplier? | Send quick inquiry to ChemWhat |
Want to be listed here as a reagent supplier? (Paid service) | Click here to contact ChemWhat |
Approved Manufacturers | |
Caming Pharmaceutical Ltd | http://www.caming.com/ |
Want to be listed as an approved manufacturer (Requires approvement)? | Please download and fill out this form and send back to approved-manufacturers@chemwhat.com |
Contact Us for Other Help | |
Contact us for other information or services | Click here to contact ChemWhat |